Mexico Oncology NGS Market (2025-2031) | Share, Size & Revenue, Trends, Outlook, Forecast, Analysis, Value, Competitive Landscape, Segmentation, Companies, Growth, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Mexico Country Macro Economic Indicators

3.2 Mexico Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Mexico Oncology NGS Market - Industry Life Cycle

3.4 Mexico Oncology NGS Market - Porter's Five Forces

3.5 Mexico Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Mexico Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Mexico Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 Mexico Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 Mexico Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in Mexico

4.2.2 Technological advancements in Next-Generation Sequencing (NGS) for oncology

4.2.3 Growing investments in healthcare infrastructure and research in Mexico

4.3 Market Restraints

4.3.1 High cost associated with NGS technologies

4.3.2 Limited reimbursement policies for NGS-based oncology tests in Mexico

4.3.3 Lack of skilled professionals and expertise in NGS data analysis

6.1 Mexico Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Mexico Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Mexico Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Mexico Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 Mexico Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 Mexico Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 Mexico Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 Mexico Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 Mexico Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 Mexico Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 Mexico Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 Mexico Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 Mexico Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 Mexico Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 Mexico Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 Mexico Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 Mexico Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 Mexico Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 Mexico Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 Mexico Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 Mexico Oncology NGS Market Export to Major Countries

7.2 Mexico Oncology NGS Market Imports from Major Countries

8.1 Adoption rate of NGS technologies in oncology diagnostics

8.2 Number of research collaborations between industry players and academic institutions in Mexico

8.3 Rate of development and approval of NGS-based oncology tests in the market

9.1 Mexico Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Mexico Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Mexico Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 Mexico Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 Mexico Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Mexico Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Mexico Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters